Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evy Lobbestael

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Neuroscience|May 16, 2020
Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and InflammationDiego Cabezudo, Veerle Baekelandt, Evy Lobbestael
Frontiers in Neuroscience|August 28, 2020
Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationMattia Volta, Patrick A Lewis, Evy Lobbestael
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 2, 2018
LRRK2 Phosphorylation: Behind the ScenesTina De Wit, Veerle Baekelandt, Evy Lobbestael
Biochemical Society Transactions|September 20, 2012
Phosphorylation of LRRK2: from kinase to substrateEvy Lobbestael, Veerle Baekelandt, Jean-Marc Taymans
Frontiers in Neuroscience|April 9, 2020
Editorial: The Role of Lipids in the Pathogenesis of Parkinson's DiseaseVeerle Baekelandt, Evy Lobbestael, Helena Xicoy, et al.
Gut|October 17, 2020
Inflammatory bowel disease and Parkinson's disease: common pathophysiological linksHo-Su Lee, Evy Lobbestael, Séverine Vermeire, et al.
CNS & Neurological Disorders Drug Targets|August 16, 2011
Kinases as targets for Parkinson's disease: from genetics to therapyRenee Vancraenenbroeck, Evy Lobbestael, Marc De Maeyer, et al.
Bioscience Reports|September 25, 2020
Pathogenic LRRK2 requires secondary factors to induce cellular toxicityEvy Lobbestael, Chris Van den Haute, Francesca Macchi, et al.
Journal of Neuropathology and Experimental Neurology|January 16, 2014
Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegenerationAnne-Sophie Van Rompuy, Evy Lobbestael, Anke Van der Perren, et al.
Frontiers in Molecular Neuroscience|November 29, 2018
RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJesús Madero-Pérez, Belén Fernández, Antonio Jesús Lara Ordóñez, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Neuroscience|May 16, 2020
Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and InflammationDiego Cabezudo, Veerle Baekelandt, Evy Lobbestael
Frontiers in Neuroscience|August 28, 2020
Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationMattia Volta, Patrick A Lewis, Evy Lobbestael
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 2, 2018
LRRK2 Phosphorylation: Behind the ScenesTina De Wit, Veerle Baekelandt, Evy Lobbestael
Biochemical Society Transactions|September 20, 2012
Phosphorylation of LRRK2: from kinase to substrateEvy Lobbestael, Veerle Baekelandt, Jean-Marc Taymans
Frontiers in Neuroscience|April 9, 2020
Editorial: The Role of Lipids in the Pathogenesis of Parkinson's DiseaseVeerle Baekelandt, Evy Lobbestael, Helena Xicoy, et al.
Gut|October 17, 2020
Inflammatory bowel disease and Parkinson's disease: common pathophysiological linksHo-Su Lee, Evy Lobbestael, Séverine Vermeire, et al.
CNS & Neurological Disorders Drug Targets|August 16, 2011
Kinases as targets for Parkinson's disease: from genetics to therapyRenee Vancraenenbroeck, Evy Lobbestael, Marc De Maeyer, et al.
Bioscience Reports|September 25, 2020
Pathogenic LRRK2 requires secondary factors to induce cellular toxicityEvy Lobbestael, Chris Van den Haute, Francesca Macchi, et al.
Journal of Neuropathology and Experimental Neurology|January 16, 2014
Long-term overexpression of human wild-type and T240R mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegenerationAnne-Sophie Van Rompuy, Evy Lobbestael, Anke Van der Perren, et al.
Frontiers in Molecular Neuroscience|November 29, 2018
RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJesús Madero-Pérez, Belén Fernández, Antonio Jesús Lara Ordóñez, et al.
Pageof 4